Although the prognostic impact of the PTEN and BAP1 mutations in renal carcinoma is under investigation, the prognostic significance of mutated PTEN and BAP1 genes has not ever been fully described in RCC. This evidence concerns the gene PTEN and renal cell adenocarcinoma.